World's Best Scientists 2026 revealed!
Mikael Eriksson

Mikael Eriksson

D-Index & Metrics

Medicine

D-Index
85
Citations
32054
World Ranking
14461
National Ranking
269

Overview

Mikael Eriksson is a researcher affiliated with the Karolinska Institute in Sweden, specializing in medicine and biochemistry, genetics, and molecular biology. Their publication record encompasses 230 works in medicine and 129 in biochemistry, genetics, and molecular biology, reflecting a broad engagement within the biomedical sciences.

Eriksson's subfields of study include genetics, oncology, pulmonary and respiratory medicine, cancer research, and pathology and forensic medicine. Their research themes frequently focus on BRCA gene mutations in cancer, global cancer incidence and screening, breast cancer treatment studies, digital radiography and breast imaging, genetic associations and epidemiology, AI in cancer detection, and cancer risks and factors.

Frequent publication venues for Eriksson comprise Cancer Research, Annals of Oncology, Breast Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), and the British Journal of Cancer. This indicates a concentration of output in well-established journals focused on oncology and cancer biology.

The following recent papers exemplify their research contributions:

  • Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women, 2021, New England Journal of Medicine
  • Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Genetic insights into biological mechanisms governing human ovarian ageing, 2021, Nature
  • Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology

Eriksson frequently collaborates with other researchers, including Kamila Czene, Per Hall, Manjeet K. Bolla, Marike Gabrielson, and D. Gareth Evans. These partnerships indicate a network of collaborative research efforts often centered on cancer genetics and epidemiology.

Best Publications

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.

    Heikki Joensuu;Mikael Eriksson;Kirsten Sundby Hall;Jörg T. Hartmann

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

    Christian H. Geisler;Arne Kolstad;Anna Laurell;Niels S. Andersen

  • Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

    Leila Dorling;Sara Carvalho;Jamie Allen

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • MicroRNA related polymorphisms and breast cancer risk

    Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study.

    L Hardell;M Eriksson;P Lenner;E Lundgren

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • A case–control study of non-Hodgkin lymphoma and exposure to pesticides

    Lennart Hardell;Mikael Eriksson

  • Soft-tissue sarcomas and exposure to chemical substances: a case-referent study.

    M Eriksson;L Hardell;N O Berg;T Möller

  • Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;S. Bielack;N. Abecassis;H.T. Aro

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

Frequent Co-Authors

Per Hall
Per Hall Karolinska Institute
Kamila Czene
Kamila Czene Karolinska Institute
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Graham G. Giles
Graham G. Giles University of Melbourne
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Melissa C. Southey
Melissa C. Southey Monash University
Stig E. Bojesen
Stig E. Bojesen University of Copenhagen
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to various healthcare careers beyond the traditional MD track. Many choose alternative pathways that are accessible, flexible, and in growing demand. If you're interested in patient care but want a direct entry point, consider nursing programs with high acceptance rates. These programs provide a practical route into healthcare and can often be completed in less time.

For students looking to advance their nursing credentials without additional standardized test requirements, lpn to rn programs without teas test offer an efficient pathway to becoming a registered nurse.

Healthcare administration is another rewarding option. You can earn a healthcare administration associate degree online and step into hospital management, policy, or support roles—all delivered with the flexibility of online learning.

If direct patient care isn't your goal, consider behind-the-scenes roles. Accredited medical billing and coding online schools that accept financial aid allow you to play a critical role in healthcare operations and insurance, making it easier to enter this essential field.

Best Scientists Citing Mikael Eriksson

Trending Scientists

Recently Published Articles